Total Payments
$187,494
2024 Payments
$32,105
Companies
33
Transactions
615
Medicare Patients
1,324
Medicare Billing
$82,376
Payment Breakdown by Category
Other$111,288 (59.4%)
Consulting$57,693 (30.8%)
Food & Beverage$12,853 (6.9%)
Travel$2,066 (1.1%)
Education$2,019 (1.1%)
Research$1,575 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $92,139 | 45 | 49.1% |
| Consulting Fee | $57,693 | 27 | 30.8% |
| Honoraria | $18,025 | 13 | 9.6% |
| Food and Beverage | $12,853 | 510 | 6.9% |
| Travel and Lodging | $2,066 | 10 | 1.1% |
| Education | $2,019 | 8 | 1.1% |
| Unspecified | $1,575 | 1 | 0.8% |
| Charitable Contribution | $1,125 | 1 | 0.6% |
Payments by Type
General
$185,919
614 transactions
Research
$1,575
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $45,964 | 97 | $0 (2024) |
| Horizon Therapeutics plc | $41,940 | 68 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $15,043 | 10 | $0 (2022) |
| Amgen Inc. | $14,515 | 24 | $0 (2024) |
| TG Therapeutics, Inc. | $14,075 | 41 | $0 (2024) |
| Genentech USA, Inc. | $12,751 | 43 | $0 (2024) |
| GENZYME CORPORATION | $8,991 | 31 | $0 (2024) |
| Greenwich Biosciences, Inc. | $8,118 | 3 | $0 (2021) |
| EMD Serono, Inc. | $5,870 | 136 | $0 (2024) |
| Celgene Corporation | $5,754 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,105 | 108 | Amgen Inc. ($14,493) |
| 2023 | $30,380 | 120 | Horizon Therapeutics plc ($17,459) |
| 2022 | $38,657 | 112 | Biogen, Inc. ($15,605) |
| 2021 | $34,625 | 46 | Horizon Therapeutics plc ($12,677) |
| 2020 | $18,656 | 33 | Greenwich Biosciences, Inc. ($4,961) |
| 2019 | $19,790 | 64 | Genentech USA, Inc. ($9,483) |
| 2018 | $11,601 | 70 | Biogen, Inc. ($9,137) |
| 2017 | $1,680 | 62 | Biogen, Inc. ($472.34) |
All Payment Transactions
615 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Neurology | ||||||
| 11/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $33.59 | General |
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Neurology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $62.25 | General |
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $45.17 | General |
| 11/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Neurology | ||||||
| 10/25/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.91 | General |
| 10/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.49 | General |
| 10/22/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Immunology | ||||||
| 10/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 234 | 279 | $63,508 | $16,325 |
| 2022 | 5 | 353 | 483 | $93,923 | $25,370 |
| 2021 | 6 | 347 | 396 | $111,416 | $19,072 |
| 2020 | 7 | 390 | 430 | $165,810 | $21,609 |
Total Patients
1,324
Total Services
1,588
Medicare Billing
$82,376
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 159 | 192 | $48,247 | $12,951 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 75 | 87 | $15,261 | $3,374 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 186 | 283 | $48,649 | $12,524 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 121 | 150 | $36,711 | $10,386 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 14 | $4,960 | $1,609 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 22 | 24 | $2,715 | $565.87 | 20.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 11 | 12 | $888.00 | $283.83 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 121 | 155 | $25,916 | $7,335 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 105 | 118 | $27,950 | $7,313 | 26.2% |
| 70551 | Mri scan brain | Facility | 2021 | 53 | 53 | $32,852 | $2,032 | 6.2% |
| 72141 | Mri scan of upper spinal canal | Facility | 2021 | 36 | 36 | $21,472 | $1,694 | 7.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 18 | 20 | $2,211 | $495.80 | 22.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 14 | 14 | $1,014 | $202.16 | 19.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 142 | 173 | $39,913 | $8,947 | 22.4% |
| 70551 | Mri scan brain | Facility | 2020 | 66 | 66 | $39,954 | $3,563 | 8.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 75 | 81 | $13,200 | $2,586 | 19.6% |
| 70553 | Mri scan of brain before and after contrast | Facility | 2020 | 31 | 32 | $27,127 | $2,551 | 9.4% |
| 72141 | Mri scan of upper spinal canal | Facility | 2020 | 47 | 47 | $27,351 | $2,448 | 8.9% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Facility | 2020 | 17 | 18 | $17,342 | $1,316 | 7.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 12 | 13 | $923.00 | $198.83 | 21.5% |
About Dr. Ben Thrower, MD
Dr. Ben Thrower, MD is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043235211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Thrower, MD has received a total of $187,494 in payments from pharmaceutical and medical device companies, with $32,105 received in 2024. These payments were reported across 615 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,139).
As a Medicare-enrolled provider, Thrower has provided services to 1,324 Medicare beneficiaries, totaling 1,588 services with total Medicare billing of $82,376. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 07/12/2006
- Last Updated 04/05/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1043235211
Products in Payments
- UPLIZNA (Drug) $41,940
- TYSABRI (Biological) $14,891
- BRIUMVI (Drug) $14,075
- UPLIZNA (Biological) $11,164
- Tysabri (Biological) $11,106
- AUBAGIO (Drug) $5,938
- OCREVUS (Biological) $5,675
- ZEPOSIA (Drug) $5,664
- DISEASE STATE (Drug) $2,602
- BAFIERTAM (Drug) $2,528
- Mavenclad (Drug) $2,473
- Enspryng (Biological) $1,948
- KESIMPTA (Drug) $510.36
- GILENYA (Drug) $506.41
- Rebif (Biological) $317.51
- MAVENCLAD (Drug) $299.33
- Ocrevus (Biological) $259.21
- COPAXONE (Drug) $253.40
- Mavenclad (Biological) $223.43
- ACTHAR (Biological) $166.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Dr. Joash Lazarus, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Neurology $946,678
Douglas Stuart, M.d, M.D
Neurology — Payments: $807,499
Neurology $807,499
Frank Berenson, Md, MD
Neurology — Payments: $628,973
Neurology $628,973
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Neurology $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322
Neurology $318,322